Dr. Christopher Bremner

Role

Hedge Fund Co-Founder, Biotech Investor

Affiliation

Bremner Capital Management / Atticus Capital

Bio Notes

Co-founded Bremner Capital Management with Tancredi Marchiolo in September 2013. London-based hedge fund. Came from Atticus Capital where he was Emerging Markets fund manager. Substantial shareholder (8.1 million shares, 5.5 percent) of Benitec Biopharma Limited, an Australian biotech company developing RNA interference combined with gene therapy. Connected to Nat Rothschild through Glen Dubin pipeline. Appears in 24 DOJ Epstein documents with 27 mentions.